Latest News & Updates
Breaking News
1 hour ago
Vaibhavi M.
Other trending news you may like to read
ANI Pharmaceutical’s ILUVIEN Study Shows Promise In Diabetic Macular Edema But Raises Safety Considerations In Phase 4 NEW DAY Trial
ANI Pharmaceuticals reports Phase 4 NEW DAY trial results for ILUVIEN in diabetic macular edema, showing sustained efficacy with safety risks including cataracts and increased intraocular pressure.
Vaibhavi M.
Plus Therapeutics Secures AMA CPT Code To Boost Adoption and Reimbursement Of CNSide CSF Tumour Cell Test
Plus Therapeutics secures AMA CPT code 0640U for CNSide CSF tumor cell test, supporting reimbursement, clinical adoption, and expanded use in leptomeningeal metastases diagnostics.
Vaibhavi M.
Merck Launches Tender Offer To Acquire Terns Pharmaceuticals In $53 Per Share Cash Deal
Merck launches tender offer to acquire Terns Pharmaceuticals at $53 per share in cash, advancing planned acquisition to strengthen pipeline, with closing expected in Q2 2026.
Vaibhavi M.
Amneal Pharmaceuticals Donates $2 Million To Support Parkinson’s Patients And Expand Access To Essential Treatments
Amneal donates $2M to support Parkinson’s patients, improving access to treatment, financial aid, and community awareness during Parkinson’s Awareness Month.
Vaibhavi M.
